Your browser doesn't support javascript.
loading
ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis.
de Oliveira, Roberta Taiane Germano; Cordeiro, João Victor Alves; Vitoriano, Bruna Ferreira; de Lima Melo, Mayara Magna; Sampaio, Letícia Rodrigues; de Paula Borges, Daniela; Magalhães, Silvia Maria Meira; Pinheiro, Ronald Feitosa.
Afiliação
  • de Oliveira RTG; Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Ceará, Brazil.
  • Cordeiro JVA; Center for Research and Drug Development (NPDM), Fortaleza, Ceará, Brazil.
  • Vitoriano BF; Post-Graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Ceará, Brazil.
  • de Lima Melo MM; Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Ceará, Brazil.
  • Sampaio LR; Center for Research and Drug Development (NPDM), Fortaleza, Ceará, Brazil.
  • de Paula Borges D; Post-Graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Ceará, Brazil.
  • Magalhães SMM; Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Ceará, Brazil.
  • Pinheiro RF; Center for Research and Drug Development (NPDM), Fortaleza, Ceará, Brazil.
Med Oncol ; 38(3): 27, 2021 Feb 17.
Article em En | MEDLINE | ID: mdl-33594613
Toll-like receptors are mutated or overexpressed in up to 50% of patients with myelodysplastic syndrome (MDS). Endogenous retroviruses (ERV) trigger TLR3 leading to interferon regulatory genes (IRFs) activation. We evaluated if the ERVs-TLR3-IRF axis activation would be linked to MDS pathogenesis and we also conducted a detailed cancer analysis of the ERVs, TLR3 and IRFs gene expression in 30 cancer types using GEPIA database. Seventy-nine bone marrow samples from patients with MDS were evaluated for cytogenetics and quantitative real­time PCR of TLR3, ERVK6, ERVW-1, ERV3-1, IRF3 and IRF7. Patients with dyserythropoiesis showed higher TLR3 (p = 0.035), ERVK6 (p = 0.001), ERVW1 (p = 0.045) and ERV3-1 (p = 0.016) expression than patients without dyserythropoiesis. Upregulation of Interferon Regulatory Factors, IRF3 and IRF7, was associated with poor prognostic markers in MDS such as > 10% of blasts (p = 0.003-IRF3; p = 0.009-IRF7), low platelets count (< 50.000/mm3) (p = 0.001-IRF3; p = 0.021-IRF7), transfusion dependence (p = 0.014-IRF3) and chromosomal abnormalities (p = 0.036-IRF7). We found strong correlations between ERVK6-ERVW1 (r = 0.800; r2 = 0.640; p = 0.000), ERVW1-ERV3-1 (r = 0.715; r2 = 0.511; p = 0.000), and IRF7-IRF3 (r = 0.567; r2 = 0.321; p = 0.000) and moderate correlation between ERVK6-ERV3-1(r = 0.485; r2 = 0.235; p = 0.000), ERVW1-IRF7 (r = 0.389; r2 = 0.151; p = 0.001), ERVW1-IRF3 (r = 0.357; r2 = 0.127; p = 0.004), ERV3-1-IRF7 (r = 0.314; r2 = 0.098; p = 0.009), and ERV3-1-IRF3 (r = 0.324; r2 = 0.104; p = 0.007). Using GEPIA Database in 30 cancer types, we detected a typical pattern of upregulation as here presented in MDS. We suggest TLR3 activation by ERVs is linked to MDS pathogenesis leading to bone marrow failure. Abnormal double-stranded RNA (dsRNA) expression of Endogenous Retroviruses (ERV) triggers TLR3 hyperactivation. This induces IRF3, IRF7, and NF-kB to translocate to the nucleus and activate transcription of IFNα/ß which binds to the type I-IFN receptor promoting interferon response. Thus, just as TLR4 induces a crucial myeloid shift, the ERVs-TLR3 axis may play an important role in establishing one of the most striking characteristics in MDS, dyserythropoiesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Retrovirus Endógenos / Fator Regulador 3 de Interferon / Fator Regulador 7 de Interferon / Receptor 3 Toll-Like Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Retrovirus Endógenos / Fator Regulador 3 de Interferon / Fator Regulador 7 de Interferon / Receptor 3 Toll-Like Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil